You are here: Industry Insights > variant

News List

Undetected coronavirus variant was in at least 15 countries before its discovery worldpharmanews
April 07, 2021
A highly contagious SARS-CoV-2 variant was unknowingly spreading for months in the United States by October 2020, according to a new study from researchers with The University of Texas at Austin COVID-19 Modeling Consortium. Scientists first ...
B.1.1.7 variant of COVID-19 spreading rapidly in United States worldpharmanews
April 02, 2021
The faster-spreading B.1.1.7 variant of SARS-CoV-2 first detected in the United Kingdom, the coronavirus that causes COVID-19, is quickly on its way to becoming the dominant variant of the virus in the United States, according to a study from ...
NIH begins trial of Moderna’s Covid-19 variant vaccine pharmaceutical-technology
April 02, 2021
The US National Institutes of Health (NIH) has initiated dosing in a new Phase I clinical trial of Moderna’s investigational vaccine candidate, mRNA-1273.351, in adult subjects.
Dyadic and Medytox to co-develop Covid-19 variant fighting vaccines pharmaceutical-business-review
March 26, 2021
US-based global biotechnology company Dyadic International has announced the expansion of its partnership with South Korea-based global research biopharmaceutical company Medytox to co-develop C1 manufactured Covid-19 vaccines.
FDA Authorizes Revisions to Fact Sheets for SARS-CoV-2 Variants under EUA americanpharmaceuticalreview
March 25, 2021
The U.S. Food and Drug Administration (FDA) authorized revised fact sheets for health care providers to include additional information on susceptibility of SARS-CoV-2 variants to each of the monoclonal antibody (mAb) therapies that are available ...
Codex DNA Releases Synthetic Genomes for Emerging SARS-CoV-2 Variants americanpharmaceuticalreview
March 18, 2021
Codex DNA announced the release of a full-length synthetic genomes for two emerging variants of the SARS-CoV-2 virus. The new genomes include the B.1.1.7 variant that initially emerged in the UK and the B.1351 variant that was first detected in ...
Avacta’s Rapid Antigen Test Confirmed to Detect SARS-CoV-2 New Variants americanpharmaceuticalreview
March 16, 2021
Avacta has announced the AffiDX® SARS-CoV-2 rapid antigen lateral flow test detects the dominant new variants of the coronavirus, known as the B117, or ‘Kent’, variant, and the D614G variant, as well as the original strain.
Variant B.1.1.7 of COVID-19 associated with a significantly higher mortality rate worldpharmanews
March 15, 2021
The highly infectious variant of COVID-19 discovered in Kent, which swept across the UK last year before spreading worldwide, is between 30 and 100 per cent more deadly than previous strains, new analysis has shown.
Novavax vaccine shows 96 per cent efficacy against original coronavirus, 86 per cent against UK variant expresspharma
March 15, 2021
Novavax plans to produce its two-shot vaccine at eight manufacturing locations, including the Serum Institute of India.
COVID-19 booster shots more likely as variants could cut efficacy of vaccines: GlobalData expresspharma
March 10, 2021
Pfizer and Moderna are already working on developing booster shots for their vaccines to improve their effectiveness against the B.1.351 strain.

Previous page 1 2 3 4 5 6 7 Next page